Menu
RedHill Biopharma Patient Assistance Program (PAP)

RedHill Biopharma Patient Assistance Program (PAP)

About the RedHill Biopharma PAP
At RedHill, we understand patients may face challenges in affording their prescribed medications. The RedHill PAP offers our medicines at no cost for patients who qualify.   

How does the RedHill Biopharma PAP Program Work?

  • The PAP is for U.S. citizens that live in one of the 50 states, the District of Columbia, or Puerto Rico and meet all eligibility criteria
  • The PAP does not constitute health insurance
  • All RedHill medications are currently available through the PAP
  • You and your U.S. licensed prescriber must complete the RedHill Biopharma PAP application. There is no cost to apply
  • We will review and confirm the information in your application and provide a response
  • If approved, you may be eligible to receive your RedHill medication at NO cost to you for up to one year
  • You may be able to reapply to the program annually if you continue to meet eligibility requirements and have a valid prescription
  • To see if you qualify for the PAP, please Click on the Download Application button below, complete the application in full, and submit as noted on the form

If you are an existing patient or prescriber and already enrolled in a separate patient assistance program for MOVANTIK®* and have received medication:
Subject to eligibility requirements, you may apply now for the RedHill PAP for assistance starting in 2021. To see if you qualify for the RedHill PAP, please Click on the Download Application button below, complete the RedHill PAP application, and submit as noted on the form.

Download Application

Questions about the RedHill PAP Program?
Should patients, families, or physicians have further questions or require additional information about the PAP or the status of your current enrollment in a separate patient assistance program for MOVANTIK®, please dial 1-844-RDHL-PAP.

 

*MOVANTIK is a registered trademark of the AstraZeneca group of companies.